MedPath

Bacitracin Zinc and Polymyxin B Sulfate

BACITRACIN ZINC AND POLYMYXIN B SULFATE OPHTHALMIC OINTMENT, USP

Approved
Approval ID

58f12018-ef71-4a2b-a6f5-6ec3ac19c353

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 8, 2009

Manufacturers
FDA

E. FOUGERA & CO., A division of Nycomed US Inc.

DUNS: 043838424

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bacitracin Zinc and Polymyxin B Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0168-0273
Application NumberANDA065022
Product Classification
M
Marketing Category
C73584
G
Generic Name
Bacitracin Zinc and Polymyxin B Sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateAugust 28, 2009
FDA Product Classification

INGREDIENTS (4)

polymyxin B sulfateActive
Quantity: 10000 1 in 1 g
Code: 19371312D4
Classification: ACTIB
Bacitracin ZincActive
Quantity: 500 1 in 1 g
Code: 89Y4M234ES
Classification: ACTIB
petrolatumInactive
Code: 4T6H12BN9U
Classification: IACT
mineral oilInactive
Code: T5L8T28FGP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bacitracin Zinc and Polymyxin B Sulfate - FDA Drug Approval Details